Recent initiatives to reduce the spread of meticillin-resistant staphylococcus aureus

British Journal of Hospital Medicine

Volumn 70, Issue 7, 2009, Pages 399-401

  Wilcox, Mark H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CROSS INFECTION; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; REVIEW; STAPHYLOCOCCUS INFECTION;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 68149091924     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2009.70.7.43123     Document Type: Review

References (15)

1. Charbonneau P, Parienti JJ, Thibon P et al (2006) Fluoroquinolone use and methicillin-resistanc Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis 42: 778-84
2. Cooke FJ, Holmes AH (2007) The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents 30: 25-9
3. Department of Health (2008) Code of practice for the prevention and control of healthcare associated infections. Department of Health, London (www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-4139336 accessed 16 April 2009)
4. Desai M, Franklin BD, Holmes AH, Trust S, Richards M, Jacklin A, Bamford KB (2006) A new approach to treatment of resistant Gram positive infections: potential impact of targeted IV to oral switch on length of stay. BMC Infect Dis 6: 94
5. European Antimicrobial Resistance Surveillance System (2005) EARSS Annual Report 2004. EARSS, Bilthoven, The Netherlands (www.rivm.nl/earss/ Images/EARSS%20annual%20report%202004%20webversie-tcm61-25345.pdf accessed 20 February 2009)
6. Gemmell CG, Edwards DI, Fraise AP et al (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57: 589-608
7. Harbarth S, Fankhauser C, Schrenzel J et al (2008) Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299: 1149-57
8. Health Protection Agency (2009) Quarterly results from the mandatory surveillance of MRSA bacteraemia, 2008. Health Protection Agency, London (www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1229502459877 accessed 20 February 2009)
9. Jeyaratnam D, Whitty CJ, Phillips K, Liu D, Orezzi C, Ajoku U, French GL (2008) Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 336: 927-30
10. Parodi S, Rhew DC, Goetz MB (2003) Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections. J Manag Care Pharm 9: 317-26
11. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R (2008) Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus isolation? A systematic review and metaanalysis. J Antimicrob Chemother 61: 26-38
12. Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S (2008) Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 62: 601-7
13. Wigglesworth N, Wilcox MH (2006) Prospective evaluation of hospital isolation room capacity. J Hasp Infect 63: 156-61
14. Wilcox MH (2005) Antibiotic prescribing as a risk factor for MRSA. Hosp Med 66: 180-4
15. Wilcox MH (2008) Screening for MRSA. BMJ 336: 899-900